User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 4 results.
    • Journal article
    Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
    Eng, Cathy Kim, Tae Won Bendell, Johanna Argilés, Guillem Tebbutt, Niall C Di Bartolomeo, Maria Falcone, Alfredo Fakih, Marwan Kozloff, Mark Segal, Neil H Sobrero, Alberto Yan, Yibing Chang, Ilsung Uyei, Anne Roberts, Louise Ciardiello, Fortunato Ahn, JB Asselah, J Badarinath, S Baijal, S Begbie, S Berry, S Canon, JL Carbone, RG Cervantes, A Cha, YJ Chang, K Chaudhry, A Chmielowska, E Cho, SH Chu, D Couture, F Cultrera, J Cunningham, D Van Cutsem, E Cuyle, PJ Davies, J Dowden, S Dvorkin, M Ganju, V Garcia, RV Kerr, R Kim, TY King, K Kortmansky, J Kozloff, M Lam, KO Lee, J Lee, AS Lesperance, B Luppi, G Ma, B Maiello, E Mandanas, R Marshall, J Marx, G Mullamitha, S Nechaeva, M Park, JO Pavlakis, N Ponce, CG Potemski, P Raouf, S Reeves, J Segal, N Siena, S Smolin, A Streb, JO Strickland, A Szutowicz-Zielinska, E Tabernero, JM Tan, B Valera, JS Van den Eynde, Marc[UCL] Vergauwe, P Vickers, M Womack, M Wroblewska, M Young, R (2019) The Lancet Oncology — Vol. 20, no.6, p. 849-861 (2019)
    • Journal article
    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial
    Tabernero, Josep Lenz, Heinz-Josef Siena, Salvatore Sobrero, Alberto Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Yoshino, Takayuki Goldberg, Richard M. Sargent, Daniel J. Wagner, Andrea Laurent, Dirk Teufel, Michael Jeffers, Michael Grothey, Axel Van Cutsem, Eric (2015) The Lancet Oncology — Vol. 16, no. 8, p. 937-948 (2015)
    • Journal article
    Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
    Dasari, Arvind Lonardi, Sara Garcia-Carbonero, Rocio Elez, Elena Yoshino, Takayuki Sobrero, Alberto Yao, James García-Alfonso, Pilar Kocsis, Judit Cubillo Gracian, Antonio Sartore-Bianchi, Andrea Satoh, Taroh Randrian, Violaine Tomasek, Jiri Chong, Geoff Paulson, Andrew Scott Masuishi, Toshiki Jones, Jeremy Csőszi, Tibor Cremolini, Chiara Ghiringhelli, Francois Shergill, Ardaman Hochster, Howard S Krauss, John Bassam, Ali Ducreux, Michel Elme, Anneli Faugeras, Laurence[UCL] Kasper, Stefan Van Cutsem, Eric Arnold, Dirk Nanda, Shivani Yang, Zhao Schelman, William R Kania, Marek Tabernero, Josep Eng, Cathy FRESCO-2 Study Investigators (2023) Lancet — Vol. 401, no. 10395, p. 41-53 (2023)
    • Journal article
    Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel Van Cutsem, Eric Sobrero, Alberto Siena, Salvatore Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Tabernero, Josep Yoshino, Takayuki Lenz, Heinz-Josef Goldberg, Richard M Sargent, Daniel J Cihon, Frank Cupit, Lisa Wagner, Andrea Laurent, Dirk CORRECT Study Group (2013) The Lancet — Vol. 381, no.9863, p. 303-12 (2013)